Pro Medicus Ltd
ASX:PME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pro Medicus Ltd
Interest Income Expense
Pro Medicus Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Pro Medicus Ltd
ASX:PME
|
Interest Income Expense
AU$146.8m
|
CAGR 3-Years
470%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
66%
|
|
|
4DMedical Ltd
ASX:4DX
|
Interest Income Expense
-AU$130.9m
|
CAGR 3-Years
-863%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Interest Income Expense
$1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Interest Income Expense
AU$565k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Interest Income Expense
AU$241k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BlinkLab Ltd
ASX:BB1
|
Interest Income Expense
-AU$9.9k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pro Medicus Ltd
Glance View
Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.
See Also
What is Pro Medicus Ltd's Interest Income Expense?
Interest Income Expense
146.8m
AUD
Based on the financial report for Dec 31, 2025, Pro Medicus Ltd's Interest Income Expense amounts to 146.8m AUD.
What is Pro Medicus Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
66%
Over the last year, the Interest Income Expense growth was 209 599%. The average annual Interest Income Expense growth rates for Pro Medicus Ltd have been 470% over the past three years , and 66% over the past ten years .